There is no answer, and the reason is that a cigarette has three different nicotine numbers attached to it — content, machine yield and absorbed dose — that differ from each other by an order of magnitude. Divide a typical 9 mg pouch by each in turn and the same pouch comes out as “about one cigarette”, “about nine cigarettes” or somewhere in between. The closest thing to a defensible figure comes from one independent meta-analysis, and it is a statement about total exposure at one strength, not a cigarette count.
This question gets asked constantly and answered badly. The bad answers are not usually dishonest — they are arithmetic performed on numbers that were never meant to be divided by each other. What follows is where each number comes from, and why the division fails.
One cigarette, three numbers
Content. How much nicotine is in the tobacco rod. The UK Committee on Toxicity, summarising Benowitz and Henningfield’s 1994 New England Journal of Medicine paper, puts it at “An average cigarette contains 8–9 mg nicotine”, and adds in a footnote that “More recent publications report a level of 10–15 mg/cigarette”. That footnote carries no citation, so treat it as a government advisory committee’s statement rather than a traceable figure.
FDA, in its January 2025 proposed nicotine standard, declines the per-cigarette framing entirely and reports content per gram instead: “the average nicotine content in the top 100 cigarette brands for 2017 is 17.2 mg/g of total tobacco”. The rule does not state how many grams of tobacco a cigarette holds, so you cannot convert it. That is not an oversight. The regulator with the most data on this deliberately does not publish a milligrams-per-cigarette number.
Machine yield. How much nicotine a smoking machine draws out under a standard protocol. This one has a hard legal value: Article 3(1) of the EU Tobacco Products Directive caps cigarettes at “1 mg of nicotine per cigarette”, measured under ISO 10315. The ISO regime is 35 mL puffs of 2 seconds every 60 seconds with ventilation holes open; the Canadian Intense regime is 55 mL every 30 seconds with the holes fully blocked. Same cigarette, different number.
Absorbed dose. How much actually reaches the bloodstream. Benowitz and Henningfield: “Typically, the cigarette delivers about 1 mg of nicotine to the circulation of the smoker, representing an absolute bioavailability of about 12 percent.” And then the sentence that should end most of these conversations: “The variation in intake per cigarette is considerable, however, ranging from 0.3 to 3.2 mg, representing a bioavailability of 3 to 40 percent, depending on how the cigarette is smoked.”
So: 8–9 mg goes in, roughly 1 mg arrives, and that 1 mg is really anywhere between 0.3 and 3.2 depending on the person and the moment. Before a pouch has entered the comparison at all, the denominator already moves by more than tenfold.
The spread, laid out
Take the median pouch from Germany’s Federal Institute for Risk Assessment survey of 44 products: 9.48 mg of nicotine per pouch, median pouch weight 0.6 g. Now divide it three ways.
| Divide a 9.48 mg pouch by… | Cigarette figure | Answer you get |
|---|---|---|
| Cigarette content | 8–9 mg (COT / Benowitz & Henningfield) | about 1 cigarette |
| Cigarette machine yield | 1 mg (EU statutory cap) | about 9.5 cigarettes |
| Cigarette absorbed dose, using the pouch’s own extracted dose | ~1 mg absorbed | a 6 mg pouch ≈ 1.8 cigarettes; a 30 mg pouch ≈ 14 |
The same product is one cigarette or fourteen depending only on which published number you pick, and all three numbers are real and correctly cited. That roughly thirteen-fold spread is the honest answer to the question in the headline.
The numerator is no better than the denominator
It would be convenient if at least the pouch side were solid. It is not.
Pouch labels are approximate. BfR’s researchers measured declared against actual content and reported: “Analyzed nicotine contents were 4.8 ± 0.4 mg, 16.3 ± 3.1 mg, and 27.1 ± 0.2 mg for the nicotine pouches declared with 6, 20, and 30 mg, respectively.” A 6 mg pouch held 4.8. A 30 held 27.1.
And content is not dose. BfR’s own assessment states that at least half the nicotine in a pouch can be absorbed, and the same research group measured what actually came out in use: “mean nicotine doses extracted were 1.8 ± 0.8 mg, 4.7 ± 3.5 mg, and 14.1 ± 3.0 mg”. Look at the standard deviations. The 20 mg product delivered 4.7 mg give or take 3.5 — the uncertainty is almost as large as the value.
There is one further wrinkle for the market leader. ZYN publishes no pouch weight in grams anywhere, and that is not an oversight either: in FDA’s own public review file for the ZYN applications, the pouch weight is redacted as confidential commercial information. So for the best-selling pouch in the United States, no milligrams-per-gram figure is derivable from the brand owner or from the regulator. If you want the full version of that problem, we have it in mg per pouch vs mg per gram.
The best available answer, and what it actually says
There is one independent synthesis, and it is worth more than everything above put together because it compares pouches and cigarettes head to head in the same people.
Heshmati and colleagues, Drug and Alcohol Dependence Reports 2025;17:100389, pooled seven randomised and crossover trials. Its funding statement reads, in full: “Funding: None”. Its competing-interests statement reads: “The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.”
The findings:
- “4 mg pouches delivered 91.73 % (95 % CI 85.03 %–98.42 %) of cigarette total nicotine exposure.”
- “4 mg pouches showed a peak nicotine concentration of 69.15 % (95 % CI 58.55 %–79.76 %) compared with cigarettes.”
- “Total nicotine exposure was significantly lower with 1.5 mg and 2 mg pouches, similar with 3.5 mg and 4 mg pouches, and significantly higher with pouches containing 8 mg or more when compared to cigarettes.”
- “Peak nicotine concentration was consistently achieved earlier with cigarettes (5–8 min) than with pouches (20–65 min).”
If you want one sentence to take away, that is it: a 4 mg pouch delivers roughly the same total nicotine as a cigarette, about two-thirds of its peak, and takes four to ten times as long to get there. It is not “equal to one cigarette” — it is equal on one axis, lower on another, and slower on a third.
Note also what those authors say about the literature they pooled: “Third, most of included studies were funded by the tobacco industry.” That matters, and it independently confirms a pattern this site has been tracking across individual studies — the trials showing pouches below cigarettes have tended to be industry-funded, and those showing pouches above have been independent or publicly funded. The dose explains part of it too. The meta-analysis reconciles the apparent conflict neatly: under 4 mg, below a cigarette; at 8 mg and up, above it.
And the authors add a line that belongs on this page: “Until this point, NPs are not considered an appropriate tool for smoking cessation.”
The comparison is biased before anyone measures anything
Here is the problem nobody mentions. Every pouch study measures venous plasma. Smoking does not deliver nicotine to the veins first.
From the National Cancer Institute’s monograph on nicotine pharmacology: nicotine “is rapidly absorbed in the alveoli of the lungs, concentrated in the pulmonary veins as a bolus”, and “smoke inhalation produces arterial boli that may be 10 times more concentrated than the levels measured in venous blood.”
A venous blood draw is the right measurement for a pouch, which releases nicotine slowly through the cheek. For a cigarette it systematically understates what the brain receives. So every published pouch-versus-cigarette peak comparison — including the ones that favour pouches — is measuring the cigarette with an instrument that flattens its defining feature. I could not find published absolute arterial concentrations after a single cigarette, only that ratio, so I am not putting a corrected number on it. The direction of the bias is clear enough.
The instability goes further. Two studies that both used a cigarette as their reference product reported venous peaks of 19.5 and 11.6 ng/mL for that same reference. They disagree by 68 per cent about the thing they were both measuring as a baseline.
Why no regulator will give you a number
Two reasons, and both are documented.
One: the last regulator that blessed a per-cigarette nicotine number formally withdrew it. In December 2008 the US Federal Trade Commission rescinded its 1966 guidance on the Cambridge Filter Method, the basis of the old tar-and-nicotine ratings. Its reasoning: “machine-based measurements of tar and nicotine yields… do not offer smokers meaningful information”, “the current yields tend to be relatively poor predictors of tar and nicotine exposure”, and the statements “are confusing at best, and are likely to mislead consumers”. The mechanism it blamed was compensation — the tendency of smokers “to take bigger, deeper, or more frequent puffs, or to otherwise alter their smoking behavior”. The FTC noted the method “was intended to produce uniform, standardized data… not to replicate actual human smoking”. Effective 26 November 2008.
That is precisely the failure mode “X cigarettes per pouch” reproduces: a standardised number presented to consumers as a dose.
Two: where authorities do map nicotine doses to smoking, they do not agree with each other. Licensed nicotine replacement therapy is the only place an official body sets this mapping, and the four I could read use three different thresholds for the same construct.
| Authority and product | How it maps dose to smoking |
|---|---|
| MHRA (UK), Nicorette Invisi 25 mg patch | “Smokers of 10 or more cigarettes per day… are recommended to use 25 mg patch” |
| Medsafe (New Zealand), same patch, same maker | “For heavier smokers (greater than 15 cigarettes a day)… one 25mg/16hr patch/day” |
| MHRA (UK), Nicorette 4 mg gum | “If the patient smokes 20 or less cigarettes a day, 2 mg nicotine gum is indicated” |
| FDA (US), nicotine polacrilex lozenge | No cigarettes-per-day instruction at all: “if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge” |
Ten a day, fifteen a day, twenty a day — or, in FDA’s case, a refusal to use cigarette counts and a switch to time-to-first-cigarette instead. Two of those are the same product from the same manufacturer, with the threshold set differently by two national regulators. If equivalence were a real quantity, it would not need four answers.
And notice what none of them do: map a dose to a number of cigarettes. They map a dose to a smoking band, which is a much weaker and much more honest claim.
There is one more thing worth putting next to the pouch data. The UK regulator’s own summary of product characteristics for 4 mg nicotine gum states that blood levels from the gum “have been shown never to exceed those obtained from smoking cigarettes”, with a peak “about 30 minutes after the start of chewing”. A licensed 4 mg buccal medicine is described by its approving regulator as never exceeding cigarette levels — and its time-course is almost identical to a pouch’s. The kinetic shape of a pouch is that of licensed buccal NRT. The dose on sale is frequently a multiple of it.
Dependence is not a cigarette count either
Underneath “how many cigarettes is this?” there is usually a better question: how much am I taking, and how hooked am I. The clinical field has an instrument for the second one, and its structure is instructive.
The Fagerström Test, as published by the NIH’s National Institute on Drug Abuse, has six items. “How many cigarettes per day do you smoke?” is one of them, banded into four coarse categories — “10 or less / 11 to 20 / 21 to 30 / 31 or more”. It carries no more weight than “How soon after you wake up do you smoke your first cigarette?”
Fagerström himself later proposed renaming the scale from the Fagerström Test for Nicotine Dependence to the Fagerström Test for Cigarette Dependence, on the explicit ground that “although nicotine is the most important addictive component of tobacco smoke, it is probably not the only substance involved in the development of tobacco dependence.” A nicotine-only equivalence cannot capture what a cigarette does, by the reasoning of the person who built the measure. (His stated affiliation is his own consultancy, and neither a funding statement nor a declaration of interests was retrievable for that paper.)
What to use instead
Three things that are actually measurable, in descending order of usefulness.
Total daily nicotine, in milligrams. An addicted smoker takes in around 24 mg a day — that comes from NCI’s monograph, where a cotinine level of 300 ng/mL corresponds to a daily intake of 24 mg using a conversion factor of 0.08. Very light smokers sit at 4–6 mg a day. Count your pouches, multiply by roughly half the declared strength, and compare to that. It is crude, but every term in it is sourced and the units are the same on both sides.
Time to first use after waking. The one dependence marker both FDA’s lozenge label and the Fagerström scale rely on, and it costs nothing to observe.
Strength, read correctly. Know whether the number on your can is per pouch or per gram, because the two differ by a factor that depends on a pouch weight most brands do not publish. The complete mg guide and every brand’s strength scale compared cover that.
FAQ
Is a 6 mg pouch like six cigarettes? No. Six milligrams is the declared content of the pouch, not the dose you receive, and a cigarette’s dose is about 1 mg absorbed from 8–9 mg of content. A 6 mg pouch was measured at 4.8 mg of actual content, delivering about 1.8 mg extracted.
Do pouches hit harder than cigarettes? Not on peak, at low strengths — the pooled figure is about 69 per cent of a cigarette’s peak for a 4 mg pouch. At 8 mg and above, total exposure exceeds a cigarette’s. And every one of those comparisons measures venous blood, which understates the cigarette.
Why is the pouch slower? Buccal absorption through the cheek against pulmonary absorption through the lungs. Cigarette peak at 5–8 minutes; pouch peak at 20–65. See how nicotine pouches actually work.
Does any regulator publish an equivalence figure? I could not find one, anywhere — FDA, MHRA, the European Commission, WHO, Health Canada, Medsafe or BfR. The framing is absent from regulation rather than condemned by it.
Can I use this to quit smoking? That is not what this page is about, and the only independent synthesis of the evidence says pouches “are not considered an appropriate tool for smoking cessation”. We cover the evidence separately in quitting smoking with pouches.
Sources
- Heshmati J, Bates EL, Shahen S, et al. Nicotine pouch pharmacokinetics compared to smoked tobacco: a systematic review and meta-analysis. Drug Alcohol Depend Rep 2025;17:100389, doi 10.1016/j.dadr.2025.100389. Funding: “None” — sciencedirect.com
- Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, TOX/2019/46, September 2019 — cot.food.gov.uk, summarising Benowitz NL, Henningfield JE, N Engl J Med 1994;331(2):123–125
- FTC, Rescission of Guidance Concerning the Cambridge Filter Method, 73 FR 74500, 8 December 2008 — ftc.gov
- FDA, proposed rule, Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products, 90 FR 5032, 16 January 2025 — federalregister.gov
- Directive 2014/40/EU, Articles 3(1) and 4(1) — eur-lex.europa.eu
- Benowitz NL, Compensatory Smoking of Low-Yield Cigarettes, in NCI Smoking and Tobacco Control Monograph 13, 2001 — cancercontrol.cancer.gov
- Henningfield JE, Schuh LM, Nicotine Pharmacology and Addictive Effects, in NCI Monograph 7 — cancercontrol.cancer.gov
- Bundesinstitut für Risikobewertung, Stellungnahme Nr. 023/2022, 7 October 2022 — bfr.bund.de
- Mallock-Ohnesorg N, et al. Small pouches, but high nicotine doses. Front Pharmacol 2024, doi 10.3389/fphar.2024.1392027. Funded by the German Federal Institute for Risk Assessment — frontiersin.org
- MHRA-approved SmPCs: Nicorette Invisi 25 mg patch — medicines.org.uk; Nicorette 4 mg gum — medicines.org.uk
- Medsafe (NZ), NICORETTE 16hr INVISIPATCH datasheet — medsafe.govt.nz
- FDA-approved OTC label, nicotine polacrilex lozenge, via DailyMed — dailymed.nlm.nih.gov
- NIDA Clinical Trials Network, Fagerström Test for Nicotine Dependence — cde.nida.nih.gov; Fagerström K, Nicotine Tob Res 2012;14(1):75–78, doi 10.1093/ntr/ntr137 — academic.oup.com
- RIVM, Measurement methods for TNCO — rivm.nl; Health Canada Official Method T-115 — healthycanadians.gc.ca
Last verified: 2 October 2026.